Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Koordinierte Versorgung bei Alkoholproblemen (CCAP)

30. Oktober 2026 aktualisiert von: Sangath

Koordinierte Versorgung bei Alkoholproblemen (CCAP): eine randomisierte kontrollierte Studie aus Goa, Indien

Parallel group individually randomised controlled trial (RCT) with stratified (by severity of drinking problem) randomisation into intervention and control arms. Aim is to test the effectiveness and cost-effectiveness of Coordinated Care for Alcohol Problems (CCAP) for the whole spectrum of drinking problems in primary care in Goa, India. Primary outcome is the drinking outcome of percentage days abstinent (PDA) at three months post randomisation. Secondary outcomes include drinking outcomes (PDA at six- and 12- months post-randomisation; percentage days heavy drinking (PDHD), intensity of drinking and remission) and drinking related outcomes (e.g., injuries, violence) at three-, six- and 12- months post- randomisation. Participants will include consenting adult (>18 years) men with drinking problems attending Primary Healthcare Centres (PHCs) and Community Healthcare Centres (CHCs) in Goa and have drinking problems defined as scoring >8 on the Alcohol Use Disorder Identification Test (AUDIT). CCAP is a multi-component evidence-informed complex intervention package for coordinating treatment for all levels of problem drinking (hazardous, harmful, dependent). For hazardous drinking, it includes Mobile based Brief Intervention Treatment (M-BIT), which is a mobile-messaging brief intervention delivered via WhatsApp over eight weeks using multimedia content including contextually relevant messages, images and videos. For harmful drinking, it includes Counselling for Alcohol Problems Plus (CAP+) which is Counselling for Alcohol Problems (CAP), an evidence-based brief psychological treatment, integrated with strategies to enhance treatment engagement (entry into and completion). For dependent drinking, it includes Community Orientated Treatment for Alcohol Dependence (CONTAD) which is supervised home-detoxification over a week followed by a psychological treatment to prevent relapse, both integrated with treatment engagement strategies. CAP+ and CONTAD will be delivered in the community by non-specialist health workers (NSHW).

Studienübersicht

Status

Rekrutierung

Bedingungen

Studientyp

Interventionell

Einschreibung (Geschätzt)

1022

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

      • Goa, Indien
        • Rekrutierung
        • Sangath

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Männlich

Beschreibung

Inclusion Criteria:

  1. Scoring positive for problem drinking (≥ 8 on the AUDIT)

  2. Have been residing in Goa for more than 12 continuous preceding months as an indicator of stability of residence which would be required both for treatment delivery and completion of outcome evaluation.

  3. Language:

    1. For hazardous drinking (AUDIT score of 8-15), patients must be able to understand at least one of the local vernacular languages (Hindi or Konkani) or English. Patients must be able to read at least one of the local vernacular languages (Hindi or Marathi) or English.
    2. For harmful and dependent drinking (AUDIT score of >15), patients must be able to understand and speak any of the local vernacular languages (Konkani, Marathi, Hindi) or English.
  4. For hazardous drinking, patients must also have access to a personal smartphone with WhatsApp.

  5. For dependent drinking (AUDIT score of >19), patients must consent for home visits and must also be eligible for home detoxification as per structured detoxification protocol.

Exclusion Criteria:

  1. For hazardous drinking, patients with significant visual or hearing impairment will be ineligible due to the audio-visual nature of the intervention.
  2. For harmful and dependent drinking, patients with significant speech, hearing, or language impairment (as evident during screening) will be excluded as the intervention is primarily a 'talking treatment'.
  3. For patients who present to the PHC/CHC needing urgent medical attention (emergency treatment or in-patient admission), screening will be deferred until their condition is stable.
  4. Those who are alcohol dependent and do not meet the eligibility criteria for home detoxification as per protocol.
  5. Those who are alcohol dependent but are currently not drinking. As AUDIT covers a period of 12 months, it will also detect those who meet the criteria for alcohol dependence over the past 12 months but are currently abstinent (hence not eligible for detoxification).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: CCAP

Hazardous drinking: M-BIT is an eight-week digital intervention delivered over WhatsApp.

Harmful drinking: CAP is a manualised brief psychological treatment for harmful drinking. CAP+ will include treatment engagement strategies integrated into CAP.

Dependent drinking: CONTAD is a manualised treatment comprising of 5-7 days of supervised home detoxification followed by relapse prevention counselling for dependent drinking.

Participants with harmful and dependent drinking level will be offered referral to the public District Hospitals or the state Psychiatric Hospital for assessment of eligibility for anti-craving medicines if available and to be prescribed and dispensed as per their Standard Operating Procedures.

Hazardous drinking: The content of the intervention includes seven themes: health education, alcohol reduction, drinking and risk management, drinking alternatives, situational content, urge management, and relapse prevention. Participants will receive texts and video-based messages building their awareness about drinking and associated harms.

Harmful drinking: CAP has three phases which are delivered in one to four sessions over six to eight weeks by NSHWs. Each session lasts between 30 to 45 minutes. The content is delivered through motivational interviewing with additional behavioural and cognitive components. CAP+ will include treatment engagement strategies integrated into CAP.

Dependent drinking: Home detoxification will be supervised by a doctor and monitored by the NSHW and a designated carer (e.g. spouse) for the patient at their home-setting. The counselling sessions are delivered by NSHWs, over 4-8 weeks and lasting 30-60 minutes each.

Aktiver Komparator: Enhanced usual care

Hazardous drinking: Brief intervention leaflet which is an information sheet/brochure with information on alcohol consumption, associated risks, and tips to manage and reduce drinking.

Harmful drinking: CAP is a manualised brief psychological treatment for harmful drinking. It has three phases which are delivered in one to four sessions over six to eight weeks by NSHWs. Each session lasts between 30 to 45 minutes. The content is delivered through motivational interviewing with additional behavioural and cognitive components. CAP has proven to be effective and cost-effective in reducing drinking in men with harmful level of drinking in a prior study. CAP can be delivered in any of the local vernacular (Hindi, Marathi, Konkani) or English.

Dependent drinking: Supported in-patient detoxification which is hospital-based detoxification delivered in secondary or tertiary care.

Hazardous drinking: An information sheet/brochure with information on alcohol consumption, associated risks, and tips to manage and reduce drinking.

Harmful drinking: CAP psychological brief treatment delivered by trained NSHWs (described above in detail).

Dependent drinking: Hospital-based detoxification delivered in secondary or tertiary care.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percentage days abstinent (PDA) [Parent trial]
Zeitfenster: 3 months post randomisation

Proportion of days abstinent in the past two weeks measured using the Timeline Follow Back (TLFB)

3 months post randomisation
Pattern of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 3 months post randomisation

Number of heavy drinking days in the past two weeks measured using the TLFB

3 months post randomisation
Treatment completion [Sub-group B Harmful Drinking]
Zeitfenster: Through the period of intervention delivery, an average of 3 months

Proportion of consented participants who go on to complete treatment defined as planned discharge which would be one of the following

  1. Received all sessions as per protocol
  2. Discharge by mutual agreement between NSHW and participant on achievement of treatment goals
  3. Referral out of the study
Through the period of intervention delivery, an average of 3 months
Intensity of drinking [Sub-group C Dependent drinking]
Zeitfenster: 3 months post randomisation

Units of alcohol consumed in the past week measured using the TLFB

3 months post randomisation

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percentage days abstinent (PDA) [Parent trial]
Zeitfenster: 6 months post randomisation

Proportion of days abstinent in the past two weeks measured using the Timeline Follow

6 months post randomisation
Percentage days abstinent (PDA) [Parent trial]
Zeitfenster: 12 months post randomisation

Proportion of days abstinent in the past two weeks measured using the Timeline Follow

12 months post randomisation
Consequences of alcohol use [Parent trial]
Zeitfenster: 3 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

3 months post randomisation
Consequences of alcohol use [Parent trial]
Zeitfenster: 6 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

6 months post randomisation
Consequences of alcohol use [Parent trial]
Zeitfenster: 12 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

12 months post randomisation
Food security [Parent trial]
Zeitfenster: 12 months post randomisation

Improvement of food security as measured using Food Insecurity Experience Scale

12 months post randomisation
Pattern of drinking [Parent trial]
Zeitfenster: 3 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

3 months post randomisation
Pattern of drinking [Parent trial]
Zeitfenster: 6 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

6 months post randomisation
Pattern of drinking [Parent trial]
Zeitfenster: 12 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

12 months post randomisation
Intensity of drinking [Parent trial]
Zeitfenster: 3 months post randomisation

Grams ethanol consumed per drinking day in the past two weeks measured using the TLFB

3 months post randomisation
Intensity of drinking [Parent trial]
Zeitfenster: 6 months post randomisation

Grams ethanol consumed per drinking day in the past two weeks measured using the TLFB

6 months post randomisation
Intensity of drinking [Parent trial]
Zeitfenster: 12 months post randomisation

Grams ethanol consumed per drinking day in the past two weeks measured using the TLFB

12 months post randomisation
Remission [Parent trial]
Zeitfenster: 3 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

3 months post randomisation
Remission [Parent trial]
Zeitfenster: 6 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

6 months post randomisation
Remission [Parent trial]
Zeitfenster: 12 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

12 months post randomisation
System-level costs [Parent trial]
Zeitfenster: Monthly, during the period of implementation

Economic costs in WHO six building blocks for delivering the interventions measured using inventory form for collecting system-level economic costs of delivering interventions (finance records and individuals involved in delivery of interventions)

Monthly, during the period of implementation
Out-of-pocket costs 1 [Parent trial]
Zeitfenster: 3 months post randomisation

Out-of-pocket costs for receiving general medical care and the related non-medical costs (e.g.: time loss, travel, etc) measured using Client Service Receipt Inventory form for collecting costs to patients who receive CCAP interventions

3 months post randomisation
Out-of-pocket costs 1 [Parent trial]
Zeitfenster: 6 months post randomisation

Out-of-pocket costs for receiving general medical care and the related non-medical costs (e.g.: time loss, travel, etc) measured using Client Service Receipt Inventory form for collecting costs to patients who receive CCAP interventions

6 months post randomisation
Out-of-pocket costs 1 [Parent trial]
Zeitfenster: 12 months post randomisation

Out-of-pocket costs for receiving general medical care and the related non-medical costs (e.g.: time loss, travel, etc) measured using Client Service Receipt Inventory form for collecting costs to patients who receive CCAP interventions

12 months post randomisation
Out-of-pocket costs 2 [Parent trial]
Zeitfenster: 3 months post randomisation

Out-of-pocket costs for receiving CCAP interventions (e.g.: time loss, travel, etc) using survey form for receiving the CCAP interventions to patients who receive CCAP interventions

3 months post randomisation
Out-of-pocket costs 2 [Parent trial]
Zeitfenster: 6 months post randomisation

Out-of-pocket costs for receiving CCAP interventions (e.g.: time loss, travel, etc) using survey form for receiving the CCAP interventions to patients who receive CCAP interventions

6 months post randomisation
Out-of-pocket costs 2 [Parent trial]
Zeitfenster: 12 months post randomisation

Out-of-pocket costs for receiving CCAP interventions (e.g.: time loss, travel, etc) using survey form for receiving the CCAP interventions to patients who receive CCAP interventions

12 months post randomisation
Disability [Parent trial]
Zeitfenster: 3 months post randomisation

Standardised disability scores used to estimate Quality-Adjusted Life Years (QALYs) using the WHO Disability Assessment Scale (WHODAS)

3 months post randomisation
Disability [Parent trial]
Zeitfenster: 6 months post randomisation

Standardised disability scores used to estimate Quality-Adjusted Life Years (QALYs) using the WHO Disability Assessment Scale (WHODAS)

6 months post randomisation
Disability [Parent trial]
Zeitfenster: 12 months post randomisation

Standardised disability scores used to estimate Quality-Adjusted Life Years (QALYs) using the WHO Disability Assessment Scale (WHODAS)

12 months post randomisation
Pattern of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 6 months post randomisation

Number of heavy drinking days in the past two weeks measured using the TLFB

6 months post randomisation
Pattern of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 12 months post randomisation

Number of heavy drinking days in the past two weeks measured using the TLFB

12 months post randomisation
Intensity of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 3 months post randomisation

Grams ethanol consumed per drinking day in past two weeks measured using the TLFB

3 months post randomisation
Intensity of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 6 months post randomisation

Grams ethanol consumed per drinking day in past two weeks measured using the TLFB

6 months post randomisation
Intensity of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 12 months post randomisation

Grams ethanol consumed per drinking day in past two weeks measured using the TLFB

12 months post randomisation
Remission [Sub-group A Hazardous drinking]
Zeitfenster: 3 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

3 months post randomisation
Remission [Sub-group A Hazardous drinking]
Zeitfenster: 6 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

6 months post randomisation
Remission [Sub-group A Hazardous drinking]
Zeitfenster: 12 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

12 months post randomisation
Percentage days abstinent (PDA) [Sub-group A Hazardous drinking]
Zeitfenster: 3 months post randomisation

Proportion of days abstinent in the past two weeks measured using the TLFB

3 months post randomisation
Percentage days abstinent (PDA) [Sub-group A Hazardous drinking]
Zeitfenster: 6 months post randomisation

Proportion of days abstinent in the past two weeks measured using the TLFB

6 months post randomisation
Percentage days abstinent (PDA) [Sub-group A Hazardous drinking]
Zeitfenster: 12 months post randomisation

Proportion of days abstinent in the past two weeks measured using the TLFB

12 months post randomisation
Pattern of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 3 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

3 months post randomisation
Pattern of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 6 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

6 months post randomisation
Pattern of drinking [Sub-group A Hazardous drinking]
Zeitfenster: 12 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

12 months post randomisation
Treatment entry [Sub-group B Harmful drinking]
Zeitfenster: 3 months post randomisation

Proportion of consented participants who receive at least one session of counselling

3 months post randomisation
Treatment entry [Sub-group B Harmful drinking]
Zeitfenster: 6 months post randomisation

Proportion of consented participants who receive at least one session of counselling

6 months post randomisation
Treatment entry [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Proportion of consented participants who receive at least one session of counselling

12 months post randomisation
Percentage days abstinent (PDA) [Sub-group B Harmful drinking]
Zeitfenster: 3 months post randomisation

Proportion of days abstinent in the past two weeks measured using the TLFB

3 months post randomisation
Percentage days abstinent (PDA) [Sub-group B Harmful drinking]
Zeitfenster: 6 months post randomisation

Proportion of days abstinent in the past two weeks measured using the TLFB

6 months post randomisation
Percentage days abstinent (PDA) [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Proportion of days abstinent in the past two weeks measured using the TLFB

12 months post randomisation
Pattern of drinking [Sub-group B Harmful drinking]
Zeitfenster: 3 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

3 months post randomisation
Pattern of drinking [Sub-group B Harmful drinking]
Zeitfenster: 6 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

6 months post randomisation
Pattern of drinking [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB

12 months post randomisation
Intensity of drinking [Sub-group B Harmful drinking]
Zeitfenster: 3 months post randomisation

Grams ethanol consumed per drinking day in past two weeks measured using the TLFB

3 months post randomisation
Intensity of drinking [Sub-group B Harmful drinking]
Zeitfenster: 6 months post randomisation

Grams ethanol consumed per drinking day in past two weeks measured using the TLFB

6 months post randomisation
Intensity of drinking [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Grams ethanol consumed per drinking day in past two weeks measured using the TLFB

12 months post randomisation
Remission [Sub-group B Harmful drinking]
Zeitfenster: 3 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

3 months post randomisation
Remission [Sub-group B Harmful drinking]
Zeitfenster: 6 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

6 months post randomisation
Remission [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

12 months post randomisation
Consequences of alcohol use [Sub-group B Harmful drinking]
Zeitfenster: 3 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

3 months post randomisation
Consequences of alcohol use [Sub-group B Harmful drinking]
Zeitfenster: 6 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

6 months post randomisation
Consequences of alcohol use [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

12 months post randomisation
Food security [Sub-group B Harmful drinking]
Zeitfenster: 12 months post randomisation

Improvement of food security as measured using Food Insecurity Experience Scale

12 months post randomisation
Intensity of drinking [Sub-group C Dependent drinking]
Zeitfenster: 6 months post randomisation

Units of alcohol consumed in the past week measured using TLFB

6 months post randomisation
Intensity of drinking [Sub-group C Dependent drinking]
Zeitfenster: 12 months post randomisation

Units of alcohol consumed in the past week measured using TLFB

12 months post randomisation
Consequences of alcohol use [Sub-group C Dependent drinking]
Zeitfenster: 3 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

3 months post randomisation
Consequences of alcohol use [Sub-group C Dependent drinking]
Zeitfenster: 6 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

6 months post randomisation
Consequences of alcohol use [Sub-group C Dependent drinking]
Zeitfenster: 12 months post randomisation

Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP)

12 months post randomisation
Food security [Sub-group C Dependent drinking]
Zeitfenster: 12 months post randomisation

Improvement of food security as measured using Food Insecurity Experience Scale

12 months post randomisation
Remission [Sub-group C Dependent drinking]
Zeitfenster: 3 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

3 months post randomisation
Remission [Sub-group C Dependent drinking]
Zeitfenster: 6 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

6 months post randomisation
Remission [Sub-group C Dependent drinking]
Zeitfenster: 12 months post randomisation

Alcohol Use Disorder Identification Test (AUDIT) score <8

12 months post randomisation
Treatment entry [Sub-group C Dependent drinking]
Zeitfenster: Through the period of intervention delivery, an average of 3 months

Proportion of consented participants who receive at least one session of counselling

Through the period of intervention delivery, an average of 3 months
Treatment completion [Sub-group C Dependent drinking]
Zeitfenster: Through the period of intervention delivery, an average of 3 months

Proportion of consented participants who go on to complete treatment defined as planned discharge which would be one of the following

  1. Received all sessions as per protocol
  2. Discharge by mutual agreement between NSHW and participant on achievement of treatment goals
  3. Referral out of the program
Through the period of intervention delivery, an average of 3 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Juni 2026

Primärer Abschluss (Geschätzt)

31. März 2027

Studienabschluss (Geschätzt)

31. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

16. November 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

21. November 2025

Zuerst gepostet (Tatsächlich)

3. Dezember 2025

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

3. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

30. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren